Blog

SmithRx is leading the industry with cutting edge PBM technology. Follow us behind the scenes as we work towards modernizing an outdated industry.

Is there a “Twindemic” upon us?

As the world battled the COVID-19 pandemic in 2020 and 2021, with heightened measures to quarantine and social distance, the influenza virus remained relatively inactive and maintained a low profile. However, the 2022 seasonal influenza virus may be rebounding in higher numbers than anticipated. Influenza, the “flu,” is a contagious respiratory disease and spreads mainly… Continue reading Is there a “Twindemic” upon us?

The end of an era.

Humira price hikes come to an end with biosimilars in 2023. After nearly two decades of patent exclusivity and $200 billion in sales, Abbvie’s monopoly on Humira (adalimumab) is ending in 2023. What does this mean for members and employer groups now that the highest grossing drug of all time finally has competition from biosimilar… Continue reading The end of an era.

The Ozempic Shortage Explained

Ozempic, manufactured by Novo Nordisk, is a medication FDA approved for treatment of type 2 diabetes. An uptick in off-label prescription use, for indications such as Obesity, has led to an increase in demand for Ozempic. The high demand has resulted in an Ozempic shortage nationwide. The manufacturer has indicated the shortage will continue until… Continue reading The Ozempic Shortage Explained

SmithRx Announces $20 Million Series B Led by Venrock

San Francisco, California — 10 March 2022, 9:30 AM PT — SmithRx, a next-generation pharmacy benefits management company, today announced the closing of a $20 million series B financing round, following a year of record growth in which the company surpassed 1,100 employer clients.  Venrock led the oversubscribed round and was joined by existing investors,… Continue reading SmithRx Announces $20 Million Series B Led by Venrock

Mark Cuban’s Cost Plus Pharmacy Unpackaged

There has been a lot of buzz recently around the new Mark Cuban Cost Plus Pharmacy. Similar excitement occured last year when Amazon announced the integration and rebranding of PillPack into the Amazon Prime experience as Amazon Pharmacy. The excitement around these known disruptors jumping into the pharmacy ecosystem demonstrates how hungry America’s employers and… Continue reading Mark Cuban’s Cost Plus Pharmacy Unpackaged

SmithRx collaborates with EHIR and industry leading PBMs to create an employer guide to pharmacy benefits

The use of Pharmacy Benefits Managers (PBMs) is the most common method implemented by employers to facilitate providing a pharmacy benefit to their employees and dependents. Unfortunately, for these employers the inter-workings of a PBM are a black box filled with misaligned incentives and no real insight into the true cost of medications. As a… Continue reading SmithRx collaborates with EHIR and industry leading PBMs to create an employer guide to pharmacy benefits

What is a Drug Acquisition Platform, and how is it different from a traditional PBM?

Pharmacy benefit managers (PBMs) were established in the 1980’s as a solution to facilitate the electronic transaction between pharmacies and plan sponsors (employers). Over time their role has evolved into not only managing the transactional aspects of the process but also controlling costs. As they gained increasing control of the market, they were able to… Continue reading What is a Drug Acquisition Platform, and how is it different from a traditional PBM?

Your PBM says they met their guarantees, but did they save you money?

We have previously discussed the standard methods used to evaluate PBMs and how contract definitions can impact PBM accountability in complex ways. In addition to contract definitions, another critical aspect to driving PBM accountability is understanding drug utilization mix. If you evaluate PBM performance using aggregate pharmacy network discounts and rebate payments (which is the… Continue reading Your PBM says they met their guarantees, but did they save you money?

Partnering with SmithRx to provide transparent pharmacy benefits helps us deliver low-cost, high-quality care. Their pass-through model is the best way to ensure prescription drug pricing is fair.

Will Young
CEO at Sana Benefits

My loudest and most challenging group was handled perfectly in the first 30 days post-go-live by SmithRx. If it were up to me, I would put every one of my new groups with SmithRx.

Ken Mensio
Vice President at Risk Strategies

Ready to make the leap?

Ready to make the leap?

99%+

client retention

1,200+

employers served

50%

potential RX savings